Skip to main content
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2022 Aug 16;43(11):3011–3012. doi: 10.1038/s41401-022-00969-5

Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Xiang-jin Zheng 1,2,#, Wen-lin Chen 3,#, Jie Yi 4, Wan Li 1,2, Jin-yi Liu 1,2, Wei-qi Fu 1,2, Li-wen Ren 1,2, Sha Li 1,2, Bin-bin Ge 1,2, Yi-hui Yang 1,2, Yi-zhi Zhang 1,2, Hong Yang 1,2, Guan-hua Du 1,2, Yu Wang 3,, Jin-hua Wang 1,2,
PMCID: PMC9622849  PMID: 35974170

Correction to: Acta Pharmacologica Sinica 10.1038/s41401-022-00917-3, published online 17 May 2022

During our recent check of our published article entitled “Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis” in Acta Pharmacologica Sinica, we found that there was a mistake in Fig. 2. We apologized that the representative image of Transwell (Fig. 2e) appeared incorrectly.

Fig. 2.

Fig. 2

e Knockdown of APOC1 inhibited the migration and invasion ability of U87-siAPOC1 cells. Scale bar = 100 μm. Scale bar = 100 μm. Data are presented as mean ± SD (n = 3). Statistical significance was determined by one-way ANOVA.

The image of U87-siAPOC1-1 in Migration present incorrect accidentally. The correct image is presented and the statistics of U87-siAPOC1-1 group have also been corrected. The authors apologize for any inconvenience caused to the journal and readers.

Contributor Information

Yu Wang, Email: ywang@pumch.cn.

Jin-hua Wang, Email: wjh@imm.ac.cn.


Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES